Adam Witty
AUTHOR

Adam Witty

Tap the gear icon above to manage new release emails.
Adam Witty is the Founder and CEO of Forbes Books, the book publishing brand of Forbes Media, publisher of Forbes Magazine. What began in the spare bedroom of his home is now one of the most respected independent business book publishers in the world with 2,000+ authors in 44 U.S. states and 14 countries. Founded in 2005, Advantage Media publishes under namesake Advantage Books and provides public relations, podcast, digital media, and serialized content services to CEOs, entrepreneurs, and leaders. In 2016 Advantage and Forbes partnered to create Forbes Books. Adam was named to the prestigious Inc. 30 Under 30 list of America’s Coolest Entrepreneurs in 2011. Advantage has been named to the Inc. 500/5000 list for six of the past eight years. Adam is the author of five books and has appeared in the USA Today, Investor’s Business Daily, Wall Street Journal, and on ABC and FOX. Adam is a leading expert globally on “Authority Media” and co-authored the best-selling book Authority Marketing. Adam’s book, Book the Business: How to Make Big Money With Your Book Without Even Selling a Single Copy, was co-authored with marketing legend Dan Kennedy. Adam’s most recent book Relentless Implementation was co-authored with Alan Mulally, retired CEO of Boeing Commercial Airplanes and Ford Motor Company. Adam is the Publisher of Forbes Books Review Magazine. Adam is an Eagle Scout, member of EO, YPO, and past Board Chair of Clemson University’s Spiro Entrepreneurship Institute and non-profit Youth Entrepreneurship South Carolina. Adam is a commercial pilot with instrument and seaplane ratings. Adam was named Charleston’s 2019 Entrepreneur of the Year by the Harbor Entrepreneur Center. Adam, wife Erin, and son Ellis are proud to call Charleston home. Their “grumpy cat” Pecan Pie is often confused to be Garfield.
Read more Read less

Best Sellers

Product List
  • The Authority Advantage cover art

    ₹680.00 or free with 30-day trial

    Free with 30-day trial